KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silicon Laboratories (SLAB) EBT (2016 - 2026)

Silicon Laboratories has reported EBT over the past 18 years, most recently at -$534000.0 for Q1 2026.

  • Quarterly results put EBT at -$534000.0 for Q1 2026, up 97.94% from a year ago — trailing twelve months through Jan 2026 was -$57.9 million (up 62.59% YoY), and the annual figure for FY2026 was -$57.9 million, up 62.59%.
  • EBT for Q1 2026 was -$534000.0 at Silicon Laboratories, up from -$9.5 million in the prior quarter.
  • Over the last five years, EBT for SLAB hit a ceiling of $47.9 million in Q1 2022 and a floor of -$70.4 million in Q4 2023.
  • Median EBT over the past 5 years was -$534000.0 (2026), compared with a mean of -$2.9 million.
  • Biggest five-year swings in EBT: skyrocketed 331.82% in 2022 and later tumbled 365.57% in 2023.
  • Silicon Laboratories' EBT stood at $26.5 million in 2022, then tumbled by 365.57% to -$70.4 million in 2023, then surged by 63.22% to -$25.9 million in 2024, then surged by 63.25% to -$9.5 million in 2025, then skyrocketed by 94.39% to -$534000.0 in 2026.
  • The last three reported values for EBT were -$534000.0 (Q1 2026), -$9.5 million (Q4 2025), and -$19.3 million (Q3 2025) per Business Quant data.